Teva, Direct Relief USA donate $3 million in contraceptives
SANTA BARBARA, Calif. — A drug maker and a charity organization are donating $3 million in contraceptives to uninsured women.
Teva Pharmaceuticals and Direct Relief USA announced the donation of 5,000 units of the intrauterine contraceptive ParaGard to clinics and health centers serving low-income people, including the EXCELth Family Health Center in New Orleans.
"Many of our clients desire effective family planning methods, but due to economic burdens, are unable to afford contraception," EXCELth medical director Monir Shalaby said. "Having this resource will greatly improve our ability to deliver holistic care and will enable patients to implement effective family planning."
Mylan launches generic version of Baxter’s Mesnex
PITTSBURGH — Mylan has released a generic version of a drug used to treat a complication of certain chemotherapy regimens, the drug maker said Tuesday.
The company announced the launch of mesna injection in the 100-mg/mL and 1,000-mg/10-mL strengths. The drug is used to reduce the incidence of ifosfamide-induced hemorrhagic cystitis, a possible complication of ifosfamide chemotherapy.
The drug is a generic version of Baxter Healthcare’s Mesnex, which has experienced shortages recently. Various versions of the drug had sales of about $11.7 million in 2011, according to IMS Health.
Merck taps ‘American Idol’ judge Randy Jackson for Taking Diabetes to Heart program
WHITEHOUSE STATION, N.J. — Drug maker Merck has introduced a new program that’s designed to provide resources and information to help patients with Type 2 diabetes commit to living a diabetes-friendly lifestyle.
The Taking Diabetes to Heart program was developed to help Type 2 diabetics understand that their condition can cause other serious health complications, including heart disease, which is a leading cause of death among people with Type 2 diabetes, Merck said. As part of the program, Merck has partnered with Grammy award-winning music producer and "American Idol" judge Randy Jackson to tour the country and educate patients about complications of Type 2 diabetes, as well as early and effective management of the ABCs of diabetes — A1C, or blood sugar, blood pressure and cholesterol — is a critical part of an effective treatment plan and can help reduce the risk of heart disease.
"Merck is committed to raising awareness of Type 2 diabetes and advancing patients’ understanding about how to help better manage the disease," said Mark Timney, president of global human health, U.S. market at Merck. "We’re thrilled to team up with Randy Jackson to help shed light on the connection between diabetes and heart disease."
For more information about Merck’s program, visit TakingDiabetestoHeart.com.